Timolol News

Few Side Effects From Long-Term Use of Combination Latanoprost Plus Timolol: Presented at ARVO

One of the largest and longest safety trials ever conducted using an ocular hypotensive drug has demonstrated no increased risk of harmful side effects when the fixed-dose combination of latanoprost and timolol is used to treat...

Travoprost Plus Timolol Offers Improved Lowering of Intraocular Pressure Compared With Travoprost Alone: Presented at ARVO

European patients with glaucoma who are being treated with the fixed-dose combination of travoprost plus timolol may achieve better intraocular pressure (IOP) compared with those who use travoprost alone.

Bimatoprost shows better efficacy, similar tolerability to timolol for chronic angle-closure glaucoma

Administering bimatoprost once daily appears more effective for lowering IOP compared with twice-daily timolol in patients with chronic angle-closure glaucoma, according to a study by researchers in several Asian countries.

Timolol may reduce post-phaco IOP increases in patients with glaucoma, exfoliation syndrome

Patients who have medically controlled glaucoma or exfoliation syndrome can experience IOP elevations within the first 24 hours after cataract surgery, a study by researchers in Israel shows. Administering timolol immediately...

Costs Rising to Make Intraocular Pressure Fall

Glaucoma medications have risen in price almost universally since 1999, with one drug doubling in cost.

Displaying results 1 to 5 out of 10

1

2

Next >

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.